Mimedx (MDXG) Long-Term Deferred Tax (2015 - 2026)

Mimedx has disclosed Long-Term Deferred Tax across 7 years of filings, most recently posting $24.1 million for Q1 2026.

• Long-Term Deferred Tax for Q1 2026 came in at $24.1 million, down 12.85% year-over-year; the trailing twelve-month figure through Mar 2026 was $24.1 million (down 12.85% YoY), and the FY2025 annual result was $19.6 million, down 30.77% from the prior year.
• Long-Term Deferred Tax came in at $24.1 million for Q1 2026 at Mimedx, up from $19.6 million in the prior quarter.
• In the past five years, Long-Term Deferred Tax ranged from a high of $40.8 million in Q4 2023 to a low of $19.6 million in Q4 2025.
• The 4-year median for Long-Term Deferred Tax is $28.0 million (2024), against an average of $29.2 million.
• Across the five-year window, Long-Term Deferred Tax plunged 30.77% in 2025 and retreated 12.85% in 2026, its largest moves.
• Mimedx's Long-Term Deferred Tax stood at $40.8 million in 2023, then slumped by 30.58% to $28.3 million in 2024, then slumped by 30.77% to $19.6 million in 2025, then grew by 23.12% to $24.1 million in 2026.
• The last three Long-Term Deferred Tax figures came in at $24.1 million (Q1 2026), $19.6 million (Q4 2025), and $21.6 million (Q3 2025), per Business Quant data.